AMRN
Amarin Corporation plc NASDAQ Listed Apr 1, 1993$15.81
After hrs
$15.81
+0.00%
Mkt Cap $327.0M
52w Low $12.30
40.8% of range
52w High $20.90
50d MA $14.61
200d MA $15.39
P/E (TTM)
—
EV/EBITDA
—
P/B
14.3x
Debt/Equity
0.0x
ROE
-7.5%
P/FCF
972.9x
RSI (14)
69.80
ATR (14)
$0.66
Beta
0.82
50d MA
$14.61
200d MA
$15.39
Avg Volume
71.0K
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally to wholesalers and specialty pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, and eicosapentaenoic acid. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.
Grand Canal Docklands · Dublin 2 · IE
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 29, 2026 | BMO | 0.01 | -0.09 | -1000.0% | 13.96 | -0.4% | +2.4% | -2.5% | +1.0% | +1.2% | +1.8% | — |
| Feb 25, 2026 | BMO | 0.07 | 0.01 | -85.7% | 15.52 | -1.0% | -9.5% | +0.5% | -2.3% | +0.9% | +3.0% | — |
| Oct 29, 2025 | BMO | 0.08 | 0.01 | -87.5% | 18.94 | -2.3% | -11.2% | -2.4% | -0.7% | -3.9% | -2.9% | — |
| Jul 30, 2025 | BMO | -0.66 | -0.03 | +95.5% | 14.65 | +2.3% | +2.2% | -3.0% | +4.4% | +1.5% | -1.6% | — |
| May 7, 2025 | BMO | -1.12 | -0.04 | +96.4% | 10.19 | -1.9% | -0.1% | +5.2% | -2.8% | +0.1% | -1.4% | — |
| Mar 12, 2025 | BMO | -1.20 | -2.40 | -100.0% | 9.41 | -13.9% | -15.0% | +2.5% | +1.0% | +0.2% | +4.2% | — |
| Oct 30, 2024 | BMO | -1.00 | -1.00 | +0.0% | 12.24 | +6.2% | -1.6% | -3.7% | +1.1% | +3.2% | +3.1% | — |
| Jul 31, 2024 | BMO | 0.10 | 0.20 | +100.0% | 15.65 | +0.5% | -12.8% | -8.9% | +3.0% | +2.2% | +7.9% | — |
| May 1, 2024 | BMO | -0.80 | -0.20 | +75.0% | 18.42 | -7.7% | -8.8% | +9.4% | -0.9% | +7.7% | -0.5% | — |
| Feb 29, 2024 | BMO | -0.01 | -0.01 | -66.7% | 26.40 | -10.6% | -18.9% | -0.9% | -12.8% | +1.8% | +0.9% | — |
| Nov 1, 2023 | BMO | -0.04 | -0.05 | -11.1% | 13.92 | +0.6% | +0.3% | -5.4% | +10.3% | +6.5% | +0.6% | — |
| Aug 2, 2023 | BMO | -0.40 | 0.40 | +200.0% | 23.80 | -2.5% | +0.0% | +0.0% | -0.8% | -2.5% | +1.7% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 25 | Goldman Sachs | Maintains | Sell → Sell | — | $16.04 | $16.19 | +0.9% | +0.9% | -1.8% | -1.2% | +3.2% | +3.6% |
| Apr 17 | Goldman Sachs | Maintains | Sell → Sell | — | $9.36 | $9.01 | -3.7% | -2.7% | +4.8% | +9.5% | -1.0% | +7.9% |
| Oct 25 | Jefferies | Downgrade | Buy → Hold | — | $15.21 | $14.94 | -1.8% | -6.1% | -2.9% | -0.5% | -0.7% | +1.6% |
| Jul 20 | Goldman Sachs | Maintains | Sell → Sell | — | $21.60 | $22.20 | +2.8% | +3.7% | +0.0% | +3.6% | -2.6% | +0.9% |
| Jul 19 | Northland Capital Markets | Maintains | Market Perform → Market Perform | — | $28.60 | $22.80 | -20.3% | -24.5% | +3.7% | +0.0% | +3.6% | -2.6% |
| Jan 6 | Jefferies | Upgrade | Hold → Buy | — | $25.20 | $26.60 | +5.6% | +14.3% | +2.8% | +16.2% | +5.8% | +7.1% |
| Oct 19 | SVB Leerink | Maintains | Market Perform → Market Perform | — | $23.40 | $23.00 | -1.7% | -8.5% | +1.9% | +2.8% | -0.9% | +3.6% |
| May 24 | Goldman Sachs | Maintains | Sell → Sell | — | $28.20 | $28.00 | -0.7% | -7.1% | +3.8% | +5.1% | +0.7% | +0.7% |
| May 6 | JP Morgan | Downgrade | Neutral → Underweight | — | $27.00 | $26.40 | -2.2% | -0.7% | -5.2% | -0.8% | -10.3% | +10.6% |
| May 5 | HC Wainwright & Co. | Downgrade | Buy → Neutral | — | $31.20 | $29.40 | -5.8% | -13.5% | -0.7% | -5.2% | -0.8% | -10.3% |
| May 5 | SVB Leerink | Downgrade | Outperform → Market Perform | — | $31.20 | $29.40 | -5.8% | -13.5% | -0.7% | -5.2% | -0.8% | -10.3% |
| Feb 16 | SVB Leerink | Maintains | Outperform → Outperform | — | $71.60 | $70.40 | -1.7% | -3.1% | -3.5% | -1.2% | -3.3% | -2.2% |
| Jan 31 | SVB Leerink | Maintains | Outperform → Outperform | — | $67.20 | $68.60 | +2.1% | +7.7% | +3.0% | -3.5% | +1.1% | +0.5% |
| May 12 | Goldman Sachs | Downgrade | Neutral → Sell | — | $92.20 | $88.00 | -4.6% | -5.6% | -2.1% | +2.8% | -1.4% | +5.1% |
| Feb 1 | SVB Leerink | Maintains | Outperform → Outperform | — | $150.00 | $160.20 | +6.8% | +7.7% | +1.5% | +7.3% | -2.3% | -2.1% |
| Sep 28 | SVB Leerink | Maintains | Outperform → Outperform | — | $76.20 | $80.00 | +5.0% | +5.0% | +1.0% | +4.2% | +1.2% | +4.9% |
| May 4 | SVB Leerink | Maintains | Outperform → Outperform | — | $146.80 | $142.00 | -3.3% | +3.8% | +1.3% | -4.3% | +1.8% | +2.5% |
| May 4 | Aegis Capital | Maintains | Buy → Buy | — | $146.80 | $142.00 | -3.3% | +3.8% | +1.3% | -4.3% | +1.8% | +2.5% |
| Apr 1 | Citigroup | Maintains | Buy → Buy | — | $80.00 | $80.40 | +0.5% | +24.5% | +4.8% | -8.4% | +0.4% | +5.0% |
| Mar 31 | Oppenheimer | Upgrade | Underperform → Perform | — | $271.60 | $83.80 | -69.1% | -70.5% | +24.5% | +4.8% | -8.4% | +0.4% |
| Mar 31 | Stifel | Maintains | Hold → Hold | — | $271.60 | $83.80 | -69.1% | -70.5% | +24.5% | +4.8% | -8.4% | +0.4% |
| Mar 31 | Jefferies | Downgrade | Buy → Hold | — | $271.60 | $83.80 | -69.1% | -70.5% | +24.5% | +4.8% | -8.4% | +0.4% |
| Mar 31 | Goldman Sachs | Downgrade | Buy → Neutral | — | $271.60 | $83.80 | -69.1% | -70.5% | +24.5% | +4.8% | -8.4% | +0.4% |
| Mar 13 | Goldman Sachs | Upgrade | Neutral → Buy | — | $230.00 | $263.60 | +14.6% | +9.1% | -18.2% | +3.2% | -3.4% | +12.7% |
| Feb 26 | Oppenheimer | Maintains | Underperform → Underperform | — | $350.00 | $338.00 | -3.4% | -7.0% | -9.8% | +0.0% | +9.7% | -3.5% |
| Feb 18 | Citigroup | Upgrade | Neutral → Buy | — | $352.40 | $362.60 | +2.9% | +3.2% | -0.5% | -1.3% | +0.3% | -2.0% |
| Dec 16 | Oppenheimer | Maintains | Underperform → Underperform | — | $482.40 | $510.20 | +5.8% | -5.1% | -6.7% | -2.4% | +1.9% | -1.1% |
| Dec 16 | Stifel | Downgrade | Buy → Hold | — | $482.40 | $510.20 | +5.8% | -5.1% | -6.7% | -2.4% | +1.9% | -1.1% |
| Nov 18 | Citigroup | Downgrade | Buy → Neutral | — | $480.40 | $482.20 | +0.4% | -5.9% | +0.6% | -10.9% | +1.3% | +1.9% |
| Nov 2 | Citigroup | Downgrade | Buy → Neutral | — | $452.80 | $447.60 | -1.1% | +1.0% | +0.5% | -1.3% | -2.8% | -3.4% |
| Oct 17 | Citigroup | Maintains | Buy → Buy | — | $402.40 | $405.00 | +0.6% | +2.5% | -2.5% | -2.0% | +0.4% | +8.3% |
| Sep 25 | Citigroup | Maintains | Buy → Buy | — | $248.00 | $244.20 | -1.5% | +4.8% | +3.5% | +2.8% | +17.6% | -1.5% |
| Sep 25 | Jefferies | Maintains | Buy → Buy | — | $248.00 | $244.20 | -1.5% | +4.8% | +3.5% | +2.8% | +17.6% | -1.5% |
| Feb 18 | SunTrust Robinson Humphrey | Upgrade | Neutral → Buy | — | $23.60 | $27.40 | +16.1% | +11.0% | +10.7% | -8.3% | +6.8% | -2.8% |
| Nov 10 | Citigroup | Maintains | Neutral → Neutral | — | $18.00 | $17.40 | -3.3% | -7.8% | +1.2% | +6.0% | +6.7% | +0.0% |
| May 12 | Citigroup | Downgrade | Buy → Neutral | — | $30.20 | $29.60 | -2.0% | -1.3% | +0.7% | +1.3% | -9.9% | +0.0% |
| Feb 28 | Aegis Capital | Maintains | Hold → Hold | — | $35.60 | $35.00 | -1.7% | -2.2% | -0.6% | +0.6% | +3.4% | +1.7% |
| Jan 16 | MKM Partners | Downgrade | Buy → Neutral | — | $48.00 | $44.20 | -7.9% | -5.8% | +0.4% | -23.8% | -2.3% | -3.0% |
| Nov 8 | Citigroup | Upgrade | Neutral → Buy | — | $28.20 | $32.20 | +14.2% | +11.3% | -1.3% | -0.6% | +0.0% | -0.6% |
| Oct 30 | Aegis Capital | Maintains | Hold → Hold | — | $42.00 | $37.60 | -10.5% | -13.8% | -8.8% | -0.6% | -1.8% | -9.9% |
| Oct 30 | Leerink Swann | Downgrade | Outperform → Market Perform | — | $42.00 | $37.60 | -10.5% | -13.8% | -8.8% | -0.6% | -1.8% | -9.9% |
| Oct 18 | Citigroup | Downgrade | Buy → Neutral | — | $40.20 | $39.80 | -1.0% | +1.0% | +13.3% | -0.9% | -3.9% | -1.4% |
| Oct 17 | JP Morgan | Downgrade | Overweight → Neutral | — | $103.40 | $41.40 | -60.0% | -61.1% | +1.0% | +13.3% | -0.9% | -3.9% |
| Oct 17 | HC Wainwright & Co. | Downgrade | Buy → Neutral | — | $103.40 | $41.40 | -60.0% | -61.1% | +1.0% | +13.3% | -0.9% | -3.9% |
| Oct 17 | H.C. Wainwright | Downgrade | Buy → Neutral | — | $103.40 | $41.40 | -60.0% | -61.1% | +1.0% | +13.3% | -0.9% | -3.9% |
| Oct 17 | Canaccord Genuity | Downgrade | Buy → Hold | — | $103.40 | $41.40 | -60.0% | -61.1% | +1.0% | +13.3% | -0.9% | -3.9% |
| Oct 16 | SunTrust Robinson Humphrey | Downgrade | Buy → Neutral | — | $103.40 | $103.40 | +0.0% | +0.0% | -61.1% | +1.0% | +13.3% | -0.9% |
| Oct 16 | Aegis Capital | Downgrade | Buy → Hold | — | $103.40 | $103.40 | +0.0% | +0.0% | -61.1% | +1.0% | +13.3% | -0.9% |
| Oct 16 | Leerink Swann | Maintains | Outperform → Outperform | — | $103.40 | $103.40 | +0.0% | +0.0% | -61.1% | +1.0% | +13.3% | -0.9% |
| Aug 13 | HC Wainwright & Co. | Upgrade | Neutral → Buy | — | $106.00 | $110.60 | +4.3% | +6.0% | +2.8% | +0.7% | +3.1% | -1.2% |
No insider trades available.
8-K
Amarin Corporation plc -- 8-K Filing
May 15
8-K
Amarin Corp Plc -- 8-K Filing
Amarin established a European license and supply agreement for VAZKEPA while maintaining U.S. market leadership for its VASCEPA franchise, supporting long-term revenue diversification and operational efficiency.
Feb 25
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Morgan Stanley | 660,218 | $9M | Added | Dec 2025 |
| 2 | Acadian Asset Management Llc | 636,769 | $9M | Added | Mar 2026 |
| 3 | Millennium Management | 300,536 | $4M | Added | Mar 2026 |
| 4 | Point72 Asset Management | 240,761 | $3M | Added | Mar 2026 |
| 5 | Waterfront Wealth Inc. | 203,338 | $3M | Added | Mar 2026 |
| 6 | Two Sigma Investments, Lp | 107,542 | $2M | Reduced | Mar 2026 |
| 7 | Citadel Advisors Llc | 80,575 | $1M | Reduced | Mar 2026 |
| 8 | Bnp Paribas Financial Markets | 75,503 | $1M | Reduced | Mar 2026 |
| 9 | Susquehanna International Group, Llp | 37,667 | $545K | Reduced | Mar 2026 |
| 10 | Jane Street Group, Llc | 32,832 | $458K | Added | Dec 2025 |
| 11 | Renaissance Technologies Llc | 19,256 | $278K | New | Mar 2026 |
| 12 | Raymond James Financial Inc | 19,075 | $276K | Reduced | Mar 2026 |
| 13 | State Of New Jersey Common Pension Fund D | 18,879 | $273K | — | Mar 2026 |
| 14 | Commonwealth Of Pennsylvania Public School Empls Retrmt Sys | 18,370 | $266K | — | Mar 2026 |
| 15 | Ubs Group Ag | 13,192 | $191K | Added | Mar 2026 |
| 16 | Hayek Kallen Investment Management | 12,809 | $185K | New | Mar 2026 |
| 17 | Wells Fargo & Company/mn | 11,380 | $165K | New | Mar 2026 |
| 18 | Johnson Financial Group, Inc. | 10,000 | $140K | — | Dec 2025 |
| 19 | Steward Partners Investment Advisory, Llc | 8,966 | $130K | Added | Mar 2026 |
| 20 | Northwestern Mutual Wealth Management Co | 5,762 | $80K | — | Dec 2025 |
Mutual Funds / ETFs (N-PORT) — Top 3
All ↗
| # | Fund | Shares | Value | Period |
|---|---|---|---|---|
| 1 | Old Westbury Small & Mid Cap Strategies Fund | 55,730 | $831K | Jan 2026 |
| 2 | Fidelity Nasdaq Composite Index Fund | 11,771 | $162K | Feb 2026 |
| 3 | VOYA MULTI-MANAGER INTERNATIONAL SMALL CAP FUND | 10,540 | $157K | Jan 2026 |
Valuation
Market Cap
$327.0M
Enterprise Value
$6.36B
P/E (TTM)
—
Forward P/E
527.00x
PEG Ratio
1.53x
P/B
14.29x
P/S
30.53x
P/FCF
972.89x
EV/EBITDA
—
Shares Out
415.0M
Financials (TTM)
Revenue
$214.9M
Net Income
-$33.6M
EBITDA
-$5.1M
Free Cash Flow
$6.7M
Op Cash Flow
$6.7M
EPS Basic
$-0.09
EPS Diluted
$-1.62
EPS Forward
$0.03
Gross Margin
52.5%
Op Margin
-17.4%
Net Margin
-15.6%
Balance Sheet
Total Assets
$670.8M
Total Liab.
$211.5M
Total Equity
$459.3M
Cash
$302.8M
LT Debt
$6.1M
Book Value/Sh
$1.11
Debt/Equity
0.03x
Current Ratio
3.34
Quick Ratio
2.33
Returns & Growth
ROE
-7.5%
ROA
-5.2%
ROIC
-2.7%
Rev Growth YoY
-20.1%
EPS Growth YoY
+97.8%
Price Returns
2W
-2.0%
1M
+4.0%
3M
+5.0%
6M
-9.3%
12M
+25.0%
Technicals
52W High
$20.90
52W Low
$12.30
50d MA
$14.61
200d MA
$15.39
RSI (14)
69.80
ATR (14)
$0.66
Beta
0.82
Avg Volume
71K
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$2.17
High
$3.00
Low
$1.50
Median
$2.00
Data updated apr 26, 2026 9:34am
· Source: financialmodelingprep.com